Status:
RECRUITING
Valvular Heart Disease in Women Registry
Lead Sponsor:
Valvular Heart Disease in Women Registry
Collaborating Sponsors:
European Association of Cardiovascular Imaging
Conditions:
Valve Disease, Heart
Gender Bias
Eligibility:
All Genders
18+ years
Brief Summary
Valvular heart disease (VHD) is a major global health issue. Untreated rheumatic heart disease persists in many regions, preventable with timely care. Higher-income countries face rising calcific valv...
Detailed Description
Valvular heart disease (VHD) is a major global public health problem (1). Many regions of the world continue to grapple with the adverse consequences of untreated rheumatic heart disease, a condition ...
Eligibility Criteria
Inclusion
- Adult patients with diagnosis of any VHD according to the current ESC guidelines.
- Admission to the VHD-W Registry collaborating center.
Exclusion
- Age less than 18 years old.
- Inability to provide informed consent per local institutional and regulatory requirements.
Key Trial Info
Start Date :
April 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT07196930
Start Date
April 1 2024
End Date
December 1 2030
Last Update
September 29 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan Heart Centre
Aswān, Egypt
2
University of Lisbon
Lisbon, Portugal